ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 732844 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 732844; 2) Community: the network communities that were significantly associated with the response to NSC 732844; 3) Molecule: the relationships between components within communities and NSC 732844; 4) MDR: the compounds that were significantly associated with the NSC 732844.

NSC Compound Enrichment Correlation
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0238174255956147 0.24763234
NSC 18805 .gamma.-Thujaplicine 0.0238174255956147 0.38034194
NSC 23925 Null 0.0238174255956147 0.34369875
NSC 244404 Null 0.0238174255956147 0.1903446
NSC 303861 L-Cysteine analog 0.0238174255956147 0.40167326
NSC 3077 s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.0238174255956147 -0.097080586
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0238174255956147 0.20495277
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0238174255956147 0.27265309
NSC 409749 Null 0.0238174255956147 0.44006871
NSC 614887 Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) 0.0238174255956147 0.47328121
Total:101  Current:45    [First] [Prev] [Next] [Last]